Primary immunodeficiencies: A field in its infancy

Science

Volumn 317, Issue 5838, 2007, Pages 617-619

  Casanova, Jean Laurent ^a,b,c   Abel, Laurent ^a,b  

^a IMAGINE INSTITUTE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNE RESPONSE; IMMUNITY; PRIMARY HEALTH CARE;

AGAMMAGLOBULINEMIA; COMBINED IMMUNODEFICIENCY; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; INFECTION SENSITIVITY; LEUKOCYTE; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SHORT SURVEY;

ADULT; ANIMALS; CHILD; DISEASE SUSCEPTIBILITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNE SYSTEM; IMMUNITY, ACTIVE; IMMUNITY, NATURAL; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFECTION; MUTATION; PHENOTYPE;

EID: 34547732069     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1142963     Document Type: Short Survey

References (45)

1. H. Ochs, C. I. E. Smith, J. Puck, Primary Immunodeficiencies: A Molecular and Genetic Approach (Oxford Univ. Press, New York, ed. 2, 2007).
2. E. R. Stiehm, R. B. Johnston Jr., Pediatr. Res. 57, 458 (2005).
3. M. E. Conley et al., Immunol. Rev. 203, 216 (2005).
4. M. S. Horwitz et al., Blood 109, 1817 (2007).
5. R. H. Buckley, Annu. Rev. Immunol. 22, 625 (2004).
6. Y. Shiloh, Nat. Rev. Cancer 3, 155 (2003).
7. I. Ulmanen, M. Halonen, T. Ilmarinen, L. Peltonen, Curr. Opin. Immunol. 17, 609 (2005).
8. J. L. Casanova, L. Abel, Nat. Rev. Immunol. 4, 55 (2004).
9. L. Notarangelo et al., J. Allergy Clin. Immunol. 117, 883 (2006).
10. G. Orth, Semin. Immunol. 18, 362 (2006).
11. J. L. Casanova, L. Abel, J. Exp. Med. 202, 197 (2005).
12. L. D. Notarangelo, E. Gambineri, R. Badolato, Adv. Immunol. 89, 321 (2006).
13. M. M. Frank, Curr. Opin. Pediatr. 17, 686 (2005).
14. H. L. Malech, D. D. Hickstein, Curr. Opin. Hematol. 14, 29 (2007).
15. S. Brydges, D. L. Kastner, Curr. Top. Microbiol. Immunol. 305, 127 (2006).
16. G. Menasche, J. Feldmann, A. Fischer, G. de Saint Basile, Immunol. Rev. 203, 165 (2005).
17. H. M. Tsai, Kidney Int. 70, 16 (2006).
18. B. Grimbacher, S. M. Holland, J. M. Puck, Immunol. Rev. 203, 244 (2005).
19. K. E. Nichols, C. S. Ma, J. L. Cannons, P. L. Schwartzberg, S. G. Tangye, Immunol. Rev. 203, 180 (2005).
20. R. A. Gatti, Acta Oncol. 40, 702 (2001).
21. T. Vulliamy, I. Dokal, Semin. Hematol. 43, 157 (2006).
22. J. L. Casanova, L. Abel, EMBO J. 26, 915 (2007).
23. S. Mathew, G. D. Overturf, Pediatr. Infect. Dis. J. 25, 255 (2006).
24. J. L. Casanova, L. Abel, Annu. Rev. Immunol. 20, 581 (2002).
25. C. Picard et al., Science 299, 2076 (2003).
26. A. Casrouge et al., Science 314, 308 (2006).
27. J. L. Casanova, E. Schurr, L. Abel, E. Skamene, Trends Immunol. 23, 469 (2002).
28. H. D. Ochs, S. F. Ziegler, T. R. Torgerson, Immunol. Rev. 203, 156 (2005).
29. N. Bidere, H. C. Su, M. J. Lenardo, Annu. Rev. Immunol. 24, 321 (2006).
30. U. Salzer, B. Grimbacher, Semin. Immunol. 18, 337 (2006).
31. G. Hollander et al., Immunol. Rev. 209, 28 (2006).
32. A. Puel, C. Picard, C. L. Ku, A. Smahi, J. L. Casanova, Curr. Opin. Immunol. 16, 34 (2004).
33. B. Schick, A. Prescher, E. Hofmann, C. Steigerwald, W. Draf, Eur. Arch. Otorhinolaryngol. 260, 518 (2003).
34. M. B. Antunes, N. A. Cohen, Curr. Opin. Allergy Clin. Immunol. 7, 5 (2007).
35. A. Alcais, C. Fieschi, L. Abel, J. L. Casanova, J. Exp. Med. 202, 1617 (2005).
36. C. Picard, J. L. Casanova, L. Abel, Curr. Opin. Immunol. 18, 383 (2006).
37. A. C. Allison, Genetics 166, 1591 (2004).
38. A. Alcais et al., Nat. Genet. 39, 517 (2007).
39. J. W. Holloway, G. H. Koppelman, Curr. Opin. Allergy Clin. Immunol. 7, 69 (2007).
40. A. Sandilands, F. J. Smith, A. D. Irvine, W. H. McLean, J. Invest. Dermatol. 127, 1282 (2007).
41. S. Onengut-Gumuscu, P. Concannon, Curr. Opin. Immunol. 18, 634 (2006).
42. S. E. Girardin, J. P. Hugot, P. J. Sansonetti, Trends Immunol. 24, 652 (2003).
43. R. H. Duerr et al., Science 314, 1461 (2006).
44. C. Bisbal, R. H. Silverman, Biochimie 89, 789 (2007).
45. We thank the members of our laboratory, our collaborators and patients worldwide, and the funding grant agencies, in particular INSERM, Agence Nationale de la Recherche (ANR), and European Union. J.L.C. is an International Scholar of the Howard Hughes Medical Institute.